Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • COVID-19

Pandemic costs not yet estimated

    • General Internal Medicine
    • Infectiology
    • News
    • Prevention and health care
    • RX
  • 2 minute read

The Corona pandemic still has us in its clutches – with immense implications for the health of the body and mind, as well as for healthcare costs. The Federal Council has adopted an initial report. However, more precise data are still lacking for an exact quantitative assessment.

The Federal Council was asked to study the financial impact of the Corona pandemic on health care stakeholders. This includes the healthcare costs incurred by the federal government, cantons and insurers as well as those insured under the mandatory health insurance scheme (OKP) as a result of the pandemic. In addition, the effects on the premiums and reserves of the insurers of the OKP will be considered. A first interim report has been prepared, which contains an initial, mainly qualitative overview of the pandemic-related health care costs per cost unit. Because the pandemic is still ongoing and due to the usual time delay for data collection and processing, reliable data are currently only available to a limited extent. Quantitative statements are therefore only possible to a limited extent. In 2020, CHF 428 million was spent on the procurement of medical supplies (including logistics) and CHF 190 million on the procurement of vaccines (including logistics). For 2021, CHF 1.2 billion is budgeted for the procurement of medical supplies and vaccinations. This amount is specifically earmarked for the procurement of Covid-19 vaccines. Federal spending in 2020 for bills already received was CHF 194 million. An additional CHF 2.4 billion has been budgeted for analyses in 2021. An average day of treatment for a Covid 19 patient in a hospital bed unit was estimated to cost between CHF 1556-1778; with intensive care in the ICU, the average day of treatment per patient cost between CHF 3556-4444. The cantons’ share is at least 55%. Accordingly, the estimated inpatient costs for the cantons for 2020 range between approximately CHF 284 and 335 million. However, care must be taken when dealing with this information. The figures given here are rough estimates and not exact values.

Because the pandemic is ongoing, much of the information and data needed to respond to the postulate will not be available until a much later date. The question of the healthcare costs caused by the pandemic can only be answered conclusively once the pandemic has ended and the necessary data have been collected and evaluated. At present, the uncertainties are too great to be able to estimate all the financial implications for the entire healthcare system. Another report is to follow by the end of 2022.

Source, “Impact of Covid 19 Pandemic on Healthcare Payers,” 04/21/2021. Available at: www.bag.admin.ch/bag/de/home.html

 

CARDIOVASC 2021; 20(4): 40 (published 1/12/21, ahead of print).
InFo NEUROLOGY & PSYCHIATRY 2021, 19(6): 40.

 

Autoren
  • Leoni Burggraf
Publikation
  • CARDIOVASC
Related Topics
  • CORONA
  • Costs
  • covid
Previous Article
  • Dementia

Clarification in practice

  • CME continuing education
  • Education
  • Geriatrics
  • Neurology
  • Psychiatry and psychotherapy
  • RX
  • Studies
View Post
Next Article
  • Wound Management

Successfully treat venous leg ulcer with compression therapy

  • Dermatology and venereology
  • Education
  • Endocrinology and Diabetology
  • Phlebology
  • RX
  • Traumatology and trauma surgery
View Post
You May Also Like
View Post
  • 27 min
  • Across All Types of Cancer

Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings

    • RX
    • CME continuing education
    • General Internal Medicine
    • Geriatrics
    • Hematology
    • Oncology
    • Pediatrics
    • Physical medicine and rehabilitation
    • Prevention and health care
    • Studies
View Post
  • 8 min
  • Obesity: More than half of those affected have fatty liver disease

From screening to multimodal intervention with GLP-1-RA or resmetirom

    • RX
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • Studies
View Post
  • 6 min
  • Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib

First-class immunomodulation combined with convenience—the data available so far is convincing

    • RX
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • Studies
View Post
  • 4 min
  • Preclinical Study on a Special Ginkgo biloba Extract

What role do proanthocyanidins play?

    • RX
    • Education
    • General Internal Medicine
    • Geriatrics
    • Neurology
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Studies
View Post
  • 6 min
  • Myasthenia gravis: immunomodulatory therapies for long-term treatment

Expanded Possibilities Thanks to Innovative Classes of Active Ingredients

    • RX
    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Ophthalmology
    • Studies
View Post
  • 10 min
  • Interstitial Lung Diseases

Update on Idiopathic Pulmonary Fibrosis

    • RX
    • CME continuing education
    • Pneumology
    • Studies
View Post
  • 7 min
  • Plastic surgery and reconstructive microsurgery for DFS

Functional limb preservation between infection control, vascular medicine and resurfacing

    • RX
    • Angiology
    • CME continuing education
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Geriatrics
    • Physical medicine and rehabilitation
    • Surgery
View Post
  • 7 min
  • Ischemic stroke: Are smaller or larger brain arteries affected?

Recent study findings on intravenous lysis therapy with fibrinolytic agents

    • RX
    • Congress Reports
    • Emergency and intensive care medicine
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Studies
    • Surgery
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
  • 2
    Functional limb preservation between infection control, vascular medicine and resurfacing
  • 3
    Update on Idiopathic Pulmonary Fibrosis
  • 4
    Update on Idiopathic Pulmonary Fibrosis
  • 5
    Current status of PAT

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.